Hanxiao Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hanxiao Chen has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Hong Chen
Department of Neurology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China, ahtcm.edu.cn
1 shared publication Lang Qin
Affiliations Center of Reproductive Medicine, Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China, The Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China
1 shared publication- Rui Gao
Reproductive Medical Center, Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University
1 shared publication Sixian Wu
Affiliation The Joint Laboratory for Reproductive Medicine of Sichuan University-The Chinese University of Hong Kong, West China Second University Hospital, Sichuan University, Chengdu, China
1 shared publicationWenming Xu
Affiliations The Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China, The Joint Laboratory for Reproductive Medicine of Sichuan University-The Chinese University of Hong Kong, West China Second University Hospital, Sichuan University, Chengdu, China
1 shared publication- Xiaohong Zhang
Emergency Medicine Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China
1 shared publication
Latest Publications
- Open Access
- 18 May 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (5) , e0249964
Clinical characteristics and laboratory features of COVID-19 in high altitude areas: A retrospective cohort study
Coronavirus disease 2019 (COVID-19) is highly contagious and has affected the whole world. We seek to investigate the clinical and laboratory characteristics of COVID-19 patients in the high altitude areas of Sichuan, China. In this retrospective cohort study, a total of 67 patients with laboratory-confirmed SARS-CoV-2 infections in Sichuan’s Ngawa Tibetan and Qiang Autonomous Prefecture were included from February 1, 2020, to March 2, 2020. Their clinical characteristics, as well as radiological and laboratory features, were extracted. Four (6.0%) patients were categorized as severe cases; 39 (58.2%) were non-severe cases, and 24 (35.8%) were asymptomatic cases. A total of 46 (68.7%) patients were associated with cluster infection events in this study. The most common symptoms were cough, sputum production, dyspnea, fatigue or myalgia, and headache. Seven (10.4%) patients showed leucopenia, and 20 (29.9%) patients showed lymphopenia. Lymphocyte counts and neutrophil-to-lymphocyte ratios (NPR) were different between the three groups. In total, 14 (20.9%) patients had thrombocytopenia, and prothrombin times (PT) and fibrinogen levels differed between groups. We also found significant differences in sodium, chloride and calcium levels between the three groups. Antiviral therapy did not lead to obvious adverse events or shortened durations from initial positive to subsequent negative nuclei acid tests. Advanced age, hypertension, high neutrophil count, the neutrophil-to-lymphocyte ratio, fibrinogen and lactate dehydrogenase levels were identified as independent risk factors for symptomatic cases of COVID-19. In conclusion, the symptoms of patients in high altitude areas were mild, and about one third were asymptomatic. We also identified several independent risk factors for symptomatic cases of COVID-19.
- 18 May 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (5) , e0249964
Open AccessClinical characteristics and laboratory features of COVID-19 in high altitude areas: A retrospective cohort study
Coronavirus disease 2019 (COVID-19) is highly contagious and has affected the whole world. We seek to investigate the clinical and laboratory characteristics of COVID-19 patients in the high altitude areas of Sichuan, China. In this retrospective cohort study, a total of 67 patients with laboratory-confirmed SARS-CoV-2 infections in Sichuan’s Ngawa Tibetan and Qiang Autonomous Prefecture were included from February 1, 2020, to March 2, 2020. Their clinical characteristics, as well as radiological and laboratory features, were extracted. Four (6.0%) patients were categorized as severe cases; 39 (58.2%) were non-severe cases, and 24 (35.8%) were asymptomatic cases. A total of 46 (68.7%) patients were associated with cluster infection events in this study. The most common symptoms were cough, sputum production, dyspnea, fatigue or myalgia, and headache. Seven (10.4%) patients showed leucopenia, and 20 (29.9%) patients showed lymphopenia. Lymphocyte counts and neutrophil-to-lymphocyte ratios (NPR) were different between the three groups. In total, 14 (20.9%) patients had thrombocytopenia, and prothrombin times (PT) and fibrinogen levels differed between groups. We also found significant differences in sodium, chloride and calcium levels between the three groups. Antiviral therapy did not lead to obvious adverse events or shortened durations from initial positive to subsequent negative nuclei acid tests. Advanced age, hypertension, high neutrophil count, the neutrophil-to-lymphocyte ratio, fibrinogen and lactate dehydrogenase levels were identified as independent risk factors for symptomatic cases of COVID-19. In conclusion, the symptoms of patients in high altitude areas were mild, and about one third were asymptomatic. We also identified several independent risk factors for symptomatic cases of COVID-19.
- Open Access
- 1 March 2021
- Published by Elsevier in Heart & Lung
- Vol. 50 (2) , 178-181
Case report: Nutrition therapy and side-effects monitoring in critically ill coronavirus disease 2019 patients
- 1 March 2021
- Published by Elsevier in Heart & Lung
- Vol. 50 (2) , 178-181
Open AccessCase report: Nutrition therapy and side-effects monitoring in critically ill coronavirus disease 2019 patients